Who’s Actually Using ‘Right-To-Try’ Laws?: A Texas Oncologist Explains his Experience
'The record with state-level right-to-try laws also suggests lackluster interest from industry. "It's telling that although 37 states have adopted these laws, when asked to provide examples of success stories, one of the primary groups pushing for their adoption can only provide the testimonies of six patients who received access to experimental medicines through a single physician in a single state," Rachel Sachs, an assistant professor of law at Washington University in St. Louis, told RAPS recently.'
Read the full article!
This quote was also featured in "Will 'Right To Try' Bill Actually Help Anyone? - Little effect from state laws, and industry largely uninterested," MedPage Today (August 11, 2017).biotechnology clinical research fda health law policy human subjects research pharmaceuticals regulation